Clinical Trials Browser

Phase 1/2 × Active not recruiting × Myasthenia Gravis × Clear all

NCT06359041 2026-02-20

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Phase 1/2 Active not recruiting

Autoimmune Diseases, Myasthenia Gravis